Drug
HS-20118
HS-20118 is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
not_yet_recruiting133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
not_yet_recruitingphase_2
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis
NCT07765628
recruitingphase_1
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
NCT06846710
recruitingphase_1
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
NCT07033234
Clinical Trials (3)
Showing 3 of 3 trials
NCT07765628Phase 2
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis
NCT06846710Phase 1
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
NCT07033234Phase 1
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3